An increase in export sales has helped the company to pay its liabilities
India-based Lincoln Pharmaceuticals has reported a net profit growth of 16.70% for the six months ending on 30 September, compared to the same period last year.
The company also reported paying all outstanding debt, making it a zero net-debt company. It most of its growth to rising sales from exports, which have grown to 56% of total sales, from 11% in 2013.
Currently, Lincoln Pharma exports to 60 different markets, including in East and West Africa, Central and South America, and Southeast Asia.
Do you know more about this story? Contact us anonymously through this link.